(Q39727820)

14 September 2017

1 reference

title

Allogeneic bone marrow transplantation in leukemia patients (English)

1 reference

14 September 2017

Bortin MM

1

1 reference

14 September 2017

publication date

1 January 1986

1 reference

Current Problems in Cancer

14 September 2017

published in

1 reference

14 September 2017

volume

10

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

1-52

1 reference

Acute lymphoblastic leukemia: Treatment

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

The ninth annual david karnofsky lecture.Treatment of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A compendium of reported human bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Immunological reconstitution of sex-linked lymphopenic immunological deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Transplantation of bone-marrow cells and fetal thymus in an infant with lymphopenic immunological deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone Marrow Transplantation with Intensive Combination Chemotherapy/Radiation Therapy (SCARI) in Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Effects of trimethoprim on leukaemic cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Gene markers in human bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone-marrow transplantation for acute leukaemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Controversies in the therapy of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A critical comparison of allogeneic bone marrow transplantation and conventional chemotherapy as treatment for acute nonlymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Initial features and prognosis in 363 children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Prognostic implications of chromosomal findings in acute lymphoblastic leukaemia at diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A score at diagnosis for predicting length of remission in childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Prognostic importance of immunologic markers in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Combination chemotherapy for acute lymphoblastic leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone-marrow relapse in acute lymphoblastic leukaemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Poor outlook for childhood acute lymphoblastic leukaemia with relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Allogeneic marrow transplantation using fractionated total body irradiation in patients with acute lymphoblastic leukemia in relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for acute lymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Chronic myelogenous leukemia--new concepts (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Prognostic features at diagnosis of chronic myelocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Staging of chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Factors influencing survival in Philadelphia chromosome positive chronic myelocytic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Marrow transplantation for patients in the chronic phase of chronic granulocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Allogeneic marrow transplantation for chronic granulocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Allogeneic bone-marrow transplantation for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Single dose total lymphoid irradiation combined with cyclophosphamide as immunosuppression for human marrow transplantation in aplastic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Interstitial pneumonitis: dose-rate vs total dose of radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Risk factors in interstitial pneumonitis following allogenic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A Prospective Analysis of Interstitial Pneumonia and Opportunistic Viral Infection among Recipients of Allogeneic Bone Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Cytomegalovirus Infections Associated with Leukocyte Transfusions

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Cytomegalovirus Immune Plasma in Bone Marrow Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

The effect of granulocyte transfusions on the incidence of cytomegalovirus infection after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

A randomized study of the prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Failure of a pan-reactive anti-T cell antibody, OKT 3, to prevent graft versus host disease in severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Response of graft versus host disease to high doses of methyl prednisolone

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Cyclosporin A for the treatment of graft-versus-host disease in man

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation in severe aplastic anaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.).

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

MNSs Antigens Graft versus Host Disease Following Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Association between pre-transplant natural kill and graft-versus-host disease after stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Mixed leukocyte culture reactivity and chronic graft-versus-host reactions (secondary disease) between allogeneic H-2k mouse strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Immunogenetics of graft-versus-host reactions to minor histocompatibility antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Chronic graft-versus-host disease in the rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Chronic graft versus host disease: a syndrome of disordered immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Prevention and therapy of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Scleroderma-like graft-versus-host disease as late consequence of bone-marrow grafting

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

The lichen planus-like eruption after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Sjögren-Type Syndrome After Allogeneic Bone-Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Thymus transplantation after allogeneic bone marrow graft to prevent chronic graft-versus-host disease in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Experience with a cooperative bone marrow transplantation program in Stockholm

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Oral acyclovir prophylactic treatment of herpes simplex infection after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Toxicity and Efficacy of Human Leukocyte Interferon for Treatment of Cytomegalovirus Pneumonia after Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Treatment of cytomegalovirus pneumonia with high-dose acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Activity of trifluorothymidine against cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Leukaemic transformation of engrafted human marrow cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Successful bone marrow transplantation for aplastic anemia using a HLA phenotypically identical parent

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for aplastic anaemia from a HL-A and MLC-identical unrelated donor

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Bone marrow transplantation for severe aplastic anemia using a phenotypically HLA-identical, SB-compatible unrelated donor

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

MISMATCHED FAMILY DONORS FOR BONE-MARROW TRANSPLANTATION AS TREATMENT FOR ACUTE LEUKAEMIA

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Long term culture of tumour-specific cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Quantitation and cloning of cytolytic T lymphocytes and their precursors

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2886%2980011-3

7 January 2021

10.1016/S0147-0272(86)80011-3

Identifiers

DOI

1 reference

14 September 2017

1 reference